EP Patent

EP3825305A1 — Process for preparing lenvatinib

Assigned to Eisai R&D Management Co Ltd · Expires 2021-05-26 · 5y expired

What this patent protects

Provided is a method for producing a compound represented by formula (IV) or a salt thereof, comprising: a step B of allowing a compound represented by formula (I) or a salt thereof to react with a compound represented by formula (II-A) or formula (II-B) wherei…

USPTO Abstract

Provided is a method for producing a compound represented by formula (IV) or a salt thereof, comprising: a step B of allowing a compound represented by formula (I) or a salt thereof to react with a compound represented by formula (II-A) or formula (II-B) wherein R 1 is a C 1-6 alkyl group, a C 2-6 alkenyl group, a C 6-10 aryl group, or a C 7-11 aralkyl group, wherein the C 1-6 alkyl group or the C 2-6 alkenyl group may have one to three substituents that may be the same or different and are selected from the group consisting of a halogen atom and a methoxy group, and wherein the C 6-10 aryl group or the C 7-11 aralkyl group may have one to three substituents that may be the same or different and are selected from the group consisting of a halogen atom, a methyl group, a methoxy group, and a nitro group; and X is a halogen atom, in the presence of a base to thereby obtain a compound represented by formula (III) wherein R 1 is the same group as above, and a step C of, after allowing the compound represented by formula (III) obtained in the step B to react without isolation with cyclopropylamine, precipitating and isolating a compound represented by formula (IV) or a salt thereof by introducing a hydrous organic solvent to a reaction solution.

Drugs covered by this patent

Patent Metadata

Patent number
EP3825305A1
Jurisdiction
EP
Classification
Expires
2021-05-26
Drug substance claim
No
Drug product claim
No
Assignee
Eisai R&D Management Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.